Chemicals

3,4-Dimethoxyphenylboronic Acid

We are 3,4-Dimethoxyphenylboronic Acid CAS:122775-35-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: 3,4-Dimethoxyphenylboronic Acid

Other Name:

3,4-Dimethoxybenzeneboronic Acid

CAS No: 122775-35-3

MF: C8H11BO4

MW: 181.98200

Density: 1.19g/cm3

Boiling point: 336.7ºC at 760 mmHg

Melting point: 245-250 °C(lit.)

Flash point: 157.4ºC

Refractive index: 1.517

UN Number: Not dangerous goods.

UN Proper Shipping Name: Not dangerous goods.

Transport hazard class: Not dangerous goods.

Packing group: Not dangerous goods.

Specification

Appearance: White powder

Assay: ≥98.0%

Water: ≤0.50%

Application

Be used as pharmaceutical intermediate.

Package: 25kg/drum, can also be designed according to customer requirements.

Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

3,4-Dimethoxyphenylboronic Acid

Related News: The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.52602-39-8 The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.5-Bromo-2-chloro-3-fluoropyridine The clinical trial International Study of Phase 3 IV RigosErtib, or INSPIRE, was finalized following guidance received from the U.S. Food and Drug Administration and European Medicines Agency.2-Bromoanisole CAS:578-57-4 DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation.DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation.

Product Name
N-VINYLCAPROLACTAM Cas:2235-00-9	View Details
3-Pyridinesulfonic Acid Cas:636-73-7	View Details
Dichlorotris(1,10-phenanthroline)ruthenium(II) hydrate Cas:207802-45-7	View Details